Literature DB >> 20406908

Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering.

Celeste Scotti1, Beatrice Tonnarelli, Adam Papadimitropoulos, Arnaud Scherberich, Stefan Schaeren, Alexandra Schauerte, Javier Lopez-Rios, Rolf Zeller, Andrea Barbero, Ivan Martin.   

Abstract

Mesenchymal stem/stromal cells (MSC) are typically used to generate bone tissue by a process resembling intramembranous ossification, i.e., by direct osteoblastic differentiation. However, most bones develop by endochondral ossification, i.e., via remodeling of hypertrophic cartilaginous templates. To date, endochondral bone formation has not been reproduced using human, clinically compliant cell sources. Here, we aimed at engineering tissues from bone marrow-derived, adult human MSC with an intrinsic capacity to undergo endochondral ossification. By analogy to embryonic limb development, we hypothesized that successful execution of the endochondral program depends on the initial formation of hypertrophic cartilaginous templates. Human MSC, subcutaneously implanted into nude mice at various stages of chondrogenic differentiation, formed bone trabeculae only when they had developed in vitro hypertrophic tissue structures. Advanced maturation in vitro resulted in accelerated formation of larger bony tissues. The underlying morphogenetic process was structurally and molecularly similar to the temporal and spatial progression of limb bone development in embryos. In particular, Indian hedgehog signaling was activated at early stages and required for the in vitro formation of hypertrophic cartilage. Subsequent development of a bony collar in vivo was followed by vascularization, osteoclastic resorption of the cartilage template, and appearance of hematopoietic foci. This study reveals the capacity of human MSC to generate bone tissue via an endochondral program and provides a valid model to study mechanisms governing bone development. Most importantly, this process could generate advanced grafts for bone regeneration by invoking a "developmental engineering" paradigm.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406908      PMCID: PMC2867676          DOI: 10.1073/pnas.1000302107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Repair of large bone defects with the use of autologous bone marrow stromal cells.

Authors:  R Quarto; M Mastrogiacomo; R Cancedda; S M Kutepov; V Mukhachev; A Lavroukov; E Kon; M Marcacci
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

Review 2.  Developmental regulation of the growth plate.

Authors:  Henry M Kronenberg
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Characterization of cells with osteogenic potential from human marrow.

Authors:  S E Haynesworth; J Goshima; V M Goldberg; A I Caplan
Journal:  Bone       Date:  1992       Impact factor: 4.398

4.  Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo.

Authors:  B A Ashton; T D Allen; C R Howlett; C C Eaglesom; A Hattori; M Owen
Journal:  Clin Orthop Relat Res       Date:  1980-09       Impact factor: 4.176

5.  The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model.

Authors:  Roberta Tasso; Franco Fais; Daniele Reverberi; Federico Tortelli; Ranieri Cancedda
Journal:  Biomaterials       Date:  2009-12-14       Impact factor: 12.479

6.  Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells.

Authors:  Anita Muraglia; Alessandro Corsi; Mara Riminucci; Maddalena Mastrogiacomo; Ranieri Cancedda; Paolo Bianco; Rodolfo Quarto
Journal:  J Cell Sci       Date:  2003-06-03       Impact factor: 5.285

Review 7.  How proteases regulate bone morphogenesis.

Authors:  Nathalie Ortega; Danielle Behonick; Dominique Stickens; Zena Werb
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

8.  Engineering endochondral bone: in vivo studies.

Authors:  Serafim M Oliveira; Dindo Q Mijares; Gloria Turner; Isabel F Amaral; Mário A Barbosa; Cristina C Teixeira
Journal:  Tissue Eng Part A       Date:  2009-03       Impact factor: 3.845

9.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine.

Authors:  J Taipale; J K Chen; M K Cooper; B Wang; R K Mann; L Milenkovic; M P Scott; P A Beachy
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

10.  Endochondral ossification is required for haematopoietic stem-cell niche formation.

Authors:  Charles K F Chan; Ching-Cheng Chen; Cynthia A Luppen; Jae-Beom Kim; Anthony T DeBoer; Kevin Wei; Jill A Helms; Calvin J Kuo; Daniel L Kraft; Irving L Weissman
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

View more
  166 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells.

Authors:  Liisa T Kuhn; Yongxing Liu; Nolan L Boyd; James E Dennis; Xi Jiang; Xiaonan Xin; Lyndon F Charles; Liping Wang; H Leonardo Aguila; David W Rowe; Alexander C Lichtler; A Jon Goldberg
Journal:  Tissue Eng Part A       Date:  2013-10-04       Impact factor: 3.845

3.  Integrative Metabolic Pathway Analysis Reveals Novel Therapeutic Targets in Osteoarthritis.

Authors:  Beatriz Rocha; Berta Cillero-Pastor; Gert Eijkel; Valentina Calamia; Patricia Fernandez-Puente; Martin R L Paine; Cristina Ruiz-Romero; Ron M A Heeren; Francisco J Blanco
Journal:  Mol Cell Proteomics       Date:  2020-01-24       Impact factor: 5.911

Review 4.  Stem cell-based tissue engineering approaches for musculoskeletal regeneration.

Authors:  Patrick T Brown; Andrew M Handorf; Won Bae Jeon; Wan-Ju Li
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration.

Authors:  Anna M McDermott; Samuel Herberg; Devon E Mason; Joseph M Collins; Hope B Pearson; James H Dawahare; Rui Tang; Amit N Patwa; Mark W Grinstaff; Daniel J Kelly; Eben Alsberg; Joel D Boerckel
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

6.  Growth differentiation factor-5 enhances in vitro mesenchymal stromal cell chondrogenesis and hypertrophy.

Authors:  Cynthia M Coleman; Erin E Vaughan; David C Browe; Emma Mooney; Linda Howard; Frank Barry
Journal:  Stem Cells Dev       Date:  2013-03-12       Impact factor: 3.272

7.  Large, stratified, and mechanically functional human cartilage grown in vitro by mesenchymal condensation.

Authors:  Sarindr Bhumiratana; Ryan E Eton; Sevan R Oungoulian; Leo Q Wan; Gerard A Ateshian; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Controlling stem cell-mediated bone regeneration through tailored mechanical properties of collagen scaffolds.

Authors:  Hongli Sun; Feng Zhu; Qingang Hu; Paul H Krebsbach
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

9.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

10.  Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage.

Authors:  Matteo Centola; Franca Abbruzzese; Celeste Scotti; Andrea Barbero; Gianluca Vadalà; Vincenzo Denaro; Ivan Martin; Marcella Trombetta; Alberto Rainer; Anna Marsano
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.